Search

Collegium Pharmaceutical Inc

Lezárt

SzektorEgészségügy

27.33 0.48

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

26.69

Maximum

27.95

Fő mutatók

By Trading Economics

Bevétel

-30M

-15M

Értékesítés

6.4M

200M

P/E

Szektor átlag

22.228

57.371

Egy részvényre jutó nyereség

1.57

Profit margin

-7.53

Munkavállalók

423

EBITDA

-20M

71M

Ajánlások

By TipRanks

Ajánlások

Erős vétel

12 hónapos előrejelzés

+81.67% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 5.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-279M

875M

Előző nyitás

26.85

Előző zárás

27.33

Hangulat hírek alapján

By Acuity

32%

68%

104 / 340 Rangsor szerint Healthcare

Collegium Pharmaceutical Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 24. 22:02 UTC

Collegium Pharmaceutical shares advanced in after-market trading, despite being below their 20-day moving average and weaker compared to a month ago.

2026. aug. 21. 20:13 UTC

Collegium Pharmaceutical Inc. shares are trading roughly flat after-market, with no specific news identified. The stock remains below its 20-day moving average.

2026. aug. 20. 20:01 UTC

Collegium Pharmaceutical shares are lower amid broader market pressures, reflecting negative sentiment following Walmart's disappointing earnings report.

2026. aug. 19. 19:56 UTC

Collegium Pharmaceutical Inc. shares are higher since Tuesday's close, reaching a session high earlier before pulling back within routine trading patterns.

2026. aug. 18. 19:56 UTC

Collegium Pharmaceutical Inc is trading higher today, though no specific news was identified to explain the movement. The stock remains below its 20-day moving average.

2026. aug. 17. 19:36 UTC

Collegium Pharmaceutical Inc shares are higher during Monday's session, reaching a peak gain earlier today before retracing. No specific news was identified for the movement.

2026. aug. 14. 19:21 UTC

Collegium Pharmaceutical Inc shares are lower today, reflecting a broader downturn in the Pharmaceuticals sector. The stock remains below its 20-day moving average.

2026. aug. 13. 22:51 UTC

Collegium Pharmaceutical Inc shares rose in after-market trading, reflecting broader market gains amid unchanged producer prices and easing inflation expectations.

2026. aug. 12. 19:51 UTC

Collegium Pharmaceutical Inc's shares are lower today, continuing a trend of recent weakness amid unusually high market volume. No specific news was identified.

2026. aug. 11. 22:01 UTC

Collegium Pharmaceutical Inc shares are higher in after-market trading, reversing earlier session dips and showing strength after three consecutive lower closes.

2026. aug. 10. 21:01 UTC

Collegium Pharmaceutical Inc shares are lower in after-market hours, continuing a trend since Monday's close, and are significantly below their 20-day moving average.

2026. aug. 7. 21:01 UTC

Collegium Pharmaceutical Inc shares are trading higher in after-market hours. No specific news was identified to explain the movement.

2026. aug. 6. 23:11 UTC

Collegium Pharmaceutical Inc shares are higher in after-market hours, recovering from an initial dip but remain below their 20-day moving average.

2026. aug. 4. 19:26 UTC

Collegium Pharmaceutical Inc shares are lower today, trading near the lower end of their one-month range, with no specific news driving the decline.

2026. aug. 3. 19:46 UTC

Collegium Pharmaceutical Inc is trading lower today, continuing a three-session decline. The stock peaked early but has since pulled back.

2026. júl. 31. 20:06 UTC

News

Collegium Pharmaceutical is under scrutiny due to concerns over its financial performance, contributing to a decline in shares during Friday's session.

2026. júl. 30. 20:09 UTC

Collegium Pharmaceutical Inc shares are lower in Thursday's session, with no specific news to explain the decline amid broader market volatility.

2026. júl. 29. 22:01 UTC

Collegium Pharmaceutical Inc is trading higher in after-market hours, continuing a positive trend with gains over four consecutive sessions amid cautious investor sentiment.

2026. júl. 28. 22:01 UTC

Collegium Pharmaceutical Inc shares are lower in after-market hours, continuing a decline from Tuesday's close amid broader market pressures, particularly in Asia.

2026. júl. 27. 19:07 UTC

News

Collegium Pharmaceutical reported first-quarter revenues of $193.5 million, surpassing expectations, while shares are trading higher amid broader strength in the pharmaceutical sector.

2026. júl. 24. 19:46 UTC

Collegium Pharmaceutical Inc shares are lower during Friday's session, with no specific news identified to explain the decline. The stock remains near its one-month trading range.

2026. júl. 22. 20:01 UTC

Collegium Pharmaceutical Inc shares are lower today, continuing a downward trend seen since Tuesday's close, with no specific news identified for the decline.

2026. júl. 21. 20:01 UTC

Collegium Pharmaceutical Inc is trading higher amid a broader market rally, with the Pharmaceuticals sector also gaining momentum. No specific news was identified.

2026. júl. 20. 19:41 UTC

News

Collegium Pharmaceutical plans to move its headquarters to Boston in 2027. Shares are lower amid significant declines in the Pharmaceuticals sub-sector.

Társak összehasonlítása

Árváltozás

Collegium Pharmaceutical Inc Előrejelzés

Célár

By TipRanks

81.67% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 49.25 USD  81.67%

Magas 60 USD

Alacsony 43 USD

4 Wall Street elemző 12 hónapos célárain alapulva a(z)Collegium Pharmaceutical Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

4 ratings

3

Vétel

1

Tartás

0

Eladás

Hangulat

By Acuity

104 / 340 Rangsor szerint Egészségügy

Hangulat hírek alapján

Bullish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag feletti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
help-icon Live chat